Description of Medical ServiceiAluRil is instilled into the bladder and held for as long as possible (30 + mins).
Description of Medical ConditioniAluRil therapy is indicated to re-establish the glycosaminoglycan layers (GAGs) of the urothelial vesical tissue in cases in which their loss can cause frequent and recurring problems such as Painful Bladder Syndrome (PBS), interstitial cystitis (IC), treatment and prevention of recurrent urinary tract infection, cystitis as a result of Bacillus Calmette ± Guerin therapy, or chemical and radiation therapy.
iAluRil therapy is also indicated in the cases where the loss of the glycosaminoglycan layers (GAGs) is associated with forms of chronic inflammation, in which their composition and integrity appears compromised in different ways.
Reason for ApplicationNew MBS item
Medical Service TypeTherapeutic
Previous Application NumberNot Applicable
PICO ConfirmationFinal Protocol (PDF 782 KB)
Final Protocol (Word 1093 KB)
Public Summary DocumentPublic Summary Document (PDF 283 KB)
Public Summary Document (Word 98 KB)